Articles on US Food and Drug Administration
Displaying all articles
A new FDA fast-track program could undermine the agency’s role as a global drug safety authority.
The psychedelic treatment is moving through the FDA clinical trial process in Colorado and elsewhere.
Hormone therapy is not a silver bullet that reverses aging, but it can significantly improve bothersome symptoms that can diminish people’s quality of life.
Decades of research show that SSRIs can be safely used during pregnancy. Meanwhile, untreated depression during pregnancy is associated with poor health outcomes like preterm birth and preeclampsia.
What a warning label gets wrong about depression and pregnancy.
A drug with antidepressant roots and opioid effects, tianeptine’s rise is largely unnoticed.
The low cost and easy availability of recreational nitrous oxide makes it an easy drug of choice, particularly for young people.
The US economy has always been a mix of government regulation and market forces. The balance between those has shifted over time, but never has one side or the other been substantively removed.
Many claims about the dangers of vaccines come from misrepresenting scientific research papers.
The FDA’s decision shines a light on some of the unique obstacles that psychedelic drugs may face on the path to approval.
Having long been considered to have ‘no accepted medical use’, psychedelics are finally being recognised as being beneficial for treating a range of mental health disorders.










